F-1/A: Empro Group Inc. Files Amended IPO Prospectus, Pivots to High-Margin Beauty Products Amid Healthcare Decline

Empro Group Inc., a Malaysian-based beauty and healthcare company, has filed an amended F-1 registration statement for its initial public offering on the Nasdaq Capital Market, seeking to raise approximately $5 million to fuel its strategic shift towards high-margin cosmetics and skincare products following a significant decline in its healthcare segment revenue.

Summary

• Empro Group Inc. is seeking to raise approximately $5.31 million in its initial public offering by offering 1,250,000 Ordinary Shares at an estimated price range of $4.00 to $4.50 per share, with net proceeds of about $4.0 million (without over-allotment option).
• The company reported total revenue of $5.48 million for the fiscal year ended December 31, 2024, a 48.37% increase from $3.70 million in 2023, but significantly lower than $10.82 million in 2022.
• Net profit for fiscal year 2024 was approximately $0.75 million, a substantial improvement from a net loss of $0.32 million in 2023, though still below the $1.17 million profit in 2022.
• Revenue from the cosmetics and skincare segment surged by approximately 783.58% to $3.36 million in 2024, now accounting for 61.21% of total revenue, primarily driven by the successful launch of the SpaceLift skincare product.
• Conversely, revenue from the healthcare business segment decreased by 35.85% to $2.12 million in 2024, down from $3.32 million in 2023, reflecting reduced demand for medical masks and COVID-19 related products.
• The company's gross profit margin improved significantly from 40.1% in 2023 to 61.8% in 2024, attributed to the strategic shift towards higher-margin cosmetic and skincare products.
• Post-IPO, founder Yeoh Chee Wei is expected to beneficially own approximately 64.7% of outstanding Ordinary Shares, making Empro Group a controlled company under Nasdaq rules, though it does not intend to rely on related exemptions immediately.

Sentiment

Score: 7

Explanation: The company demonstrates a strong strategic pivot towards higher-margin beauty products, resulting in significant revenue growth in that segment and a return to overall profitability in 2024. The IPO provides crucial capital for expansion. However, the overall revenue is still substantially below 2022 levels, and there are notable risks related to market competition, international expansion, and reliance on key suppliers, warranting a cautious but positive outlook.

Positives

• The company returned to profitability in fiscal year 2024 with a net profit of $0.75 million, a significant turnaround from a $0.32 million net loss in 2023.
• Strong growth in the cosmetics and skincare segment, with revenue increasing by approximately 783.58% to $3.36 million in 2024, driven by new product launches like SpaceLift.
• Improved gross profit margin from 40.1% in 2023 to 61.8% in 2024, reflecting a successful strategic pivot towards higher-margin beauty products.
• Established distribution network through major retailers like Watsons and Sasa, as well as online platforms such as Shopee and Lazada, ensuring broad market coverage.
• Possesses a rich brand history spanning nearly two decades and has received numerous industry accolades and awards for its beauty and healthcare products.
• Commitment to product safety and quality, evidenced by rigorous testing and certifications from reputable international organizations like TV-SD, MYCO2, Nelson Labs, and SGS, and compliance with Malaysian regulatory bodies (MDA, NPRA).
• Strategic plans for geographical expansion into new international markets including Europe, India, the United States, Canada, and other ASEAN countries.
• Investment in new technologies, including the development of an in-house e-commerce application for enhanced B2B and B2C customer engagement and efficient operations.
• Robust and experienced management team with diverse professional backgrounds, including expertise in financial reporting, regulatory compliance, and international trade.

Negatives

• Total revenue in 2024 ($5.48 million) remains significantly lower than the $10.82 million reported in 2022, indicating a substantial overall decline from pre-pandemic levels.
• The healthcare business segment experienced a considerable revenue decrease of 35.85% in 2024, from $3.32 million in 2023 to $2.12 million, due to waning demand for COVID-19 related products.
• New investors in the IPO will experience immediate and substantial dilution in net tangible book value of $3.52 per share (assuming midpoint IPO price and no over-allotment).
• The company does not expect to pay dividends in the foreseeable future, requiring investors to rely solely on share price appreciation for returns.
• Reliance on a limited number of ODM/OEM and packaging supply partners (Jingga Anggun and Mosfac) introduces supply chain risks and potential disruptions.
• Trade receivables increased significantly to $2.49 million in 2024, with only 16.09% collected as of March 26, 2025, raising concerns about cash flow and collection efficiency.
• The company will incur substantial increased costs as a public company, including legal, accounting, and compliance expenses.
• The founder, Mr. Yeoh, will control approximately 64.7% of outstanding shares post-IPO, making the company a 'controlled company' and potentially limiting the influence of other shareholders on corporate governance matters.

Risks

• Operating in a dynamic and highly competitive healthcare and beauty industry with a limited and evolving operating history, where historical results may not indicate future performance.
• Success is dependent on the continued popularity of products and the ability to anticipate and respond to changes in industry trends and consumer preferences in a timely manner.
• Uncertainty that revenue from the healthcare business segment will not continue to decrease, or that growth in the cosmetics and skincare segment will sufficiently offset declines.
• New product introductions may not be as successful as anticipated, potentially harming business, prospects, financial condition, and results of operations.
• Business depends on the quality, effectiveness, and safety of products; failure to comply with laws or product defects could lead to recalls, penalties, and product liability claims.
• Inability to successfully implement growth strategies or manage growth effectively or efficiently.
• May not be able to achieve or maintain profitability in the future due to significant future expenditures and market factors.
• Reliance on third-party e-commerce platforms (Shopee, Lazada, Watsons, Sasa) for online sales; interruptions or termination of cooperation could materially and adversely affect business.
• The potential sale of counterfeit products may affect reputation and profitability.
• Operating results could be materially harmed if unable to accurately forecast consumer demand or adequately manage inventory.
• Brand and reputation could be harmed by negative publicity regarding the company, its products, operations, management, or business partners.
• The market for beauty products in Malaysia and Southeast Asia may not grow as quickly as expected, or at all.
• Changes to the pricing of healthcare and beauty products could adversely affect results of operations.
• Inability to conduct sales and marketing efforts in a cost-effective and efficient manner could materially and adversely affect results.
• Reliance on a limited number of ODM/OEM and packaging supply partners; loss or business challenges at these partners could harm the brand and operations.
• Susceptibility to supply shortages and interruptions, long lead times, and price fluctuations for raw materials and ingredients.
• Compliance with numerous complex and costly health, safety, and environmental regulations.
• Exposure to export and import control laws and regulations that could impair international competitiveness or subject to liability.
• Fluctuations in Malaysian Ringgit (MYR) exchange rates could adversely affect business and securities value.
• Inflationary pressures in Malaysia and ASEAN countries may prompt government action, leading to decreased profitability.
• Reliance on third-party service providers for logistics services; failure to provide reliable services could adversely affect business and reputation.
• Delivery, return, and exchange policies may adversely affect results of operations due to costs or misuse.
• Failure to maintain or renew current leases or locate desirable alternatives for facilities could materially and adversely affect business.
• Expansion into international markets will expose the company to significant regulatory, economic, and political risks.
• An economic downturn may adversely affect consumer discretionary spending and demand for products and services.
• Risks related to the collection, storage, processing, and use of customer data, including privacy, data security, and cybersecurity compliance.
• Proprietary data analytics algorithms for consumer preference prediction and content recommendation may be flawed or ineffective.
• Dependence on information technology; inability to protect against service interruptions, data corruption, cyber-based attacks, or network security breaches.
• Failure to maintain and upgrade information technology systems.
• Compliance with Malaysia's Personal Data Protection Act 2010 and other data-privacy related laws may entail significant expenses.
• Real or perceived inaccuracies in operating metrics may harm reputation.
• Payment methods accepted subject the company to third-party payment-related risks.
• Ability to enrich content offerings could be impaired if cooperation with third-party content providers or retention of in-house talent fails.
• Insufficient cash from operations to meet current or future operating needs and expenditures, potentially requiring additional financing.
• Subject to intellectual property infringement claims or inability to protect own intellectual property.
• Misconduct or improper activities by employees or business partners.
• Failure to obtain and maintain requisite licenses, permits, registrations, or filings.
• Acquisition activities and other strategic transactions may present managerial, integration, operational, and financial risks.
• Quarterly operating results may fluctuate due to seasonality and other factors, making results difficult to predict.
• Disruptions in financial markets and economic conditions could affect ability to raise capital.
• Any catastrophe, including natural catastrophes, health epidemics, and other extraordinary events, could disrupt business operations.
• The continued and collaborative efforts of senior management and key employees are crucial; loss of their services could harm business.
• May become a party to litigation, legal disputes, claims, or administrative proceedings.
• Performance is dependent on the performance of the economy and consumer spending patterns in operating countries.
• Financial performance is subject to political, economic, social, regulatory, and other developments in operating countries.
• No public market for Ordinary Shares prior to offering; market price may be volatile or decline regardless of operating performance.
• Immediate and substantial dilution in net tangible book value for Ordinary Shares purchased.
• If securities or industry analysts cease to publish research or adversely change recommendations, market price and trading volume could decline.
• Techniques employed by short sellers may drive down the market price of Ordinary Shares.
• Substantial future sales or perceived potential sales of Ordinary Shares in the public market could cause the price to decline.
• Difficulties in protecting interests and limited ability to protect rights through U.S. courts due to Cayman Islands incorporation.
• Certain judgments obtained against the company by shareholders may not be enforceable.
• As a foreign private issuer, the company is exempt from certain Nasdaq corporate governance standards applicable to U.S. issuers, potentially offering less protection to investors.
• If the company cannot continue to satisfy Nasdaq Capital Market listing requirements, securities may be delisted.
• Classification as a passive foreign investment company (PFIC) could have adverse U.S. federal income tax consequences for U.S. taxpayers.
• Substantial increased costs as a result of being a public company.
• Management has broad discretion to determine how to use funds raised in the offering.
• As an emerging growth company, the company may take advantage of certain exemptions from disclosure requirements, making performance comparisons difficult.
• Pre-IPO shareholders will be able to sell their shares after the offering, potentially impacting the trading price.
• Shareholders may be held liable for claims by third parties against the company to the extent of distributions received upon redemption of their shares.
• The company is controlled by a single shareholder (Mr. Yeoh), whose interests may differ from other shareholders.
• Insufficient funds to satisfy indemnification claims of directors and officers.

Future Outlook

Empro Group plans to expand its product offerings with new brands like Premio and Mios, and further develop its SpaceLift skincare product. The company intends to expand geographically into new international markets including Europe, India, the United States, Canada, Thailand, Cambodia, UAE, Singapore, Hong Kong, Macau & China, and South Africa within the next five years. It will invest in new technologies, such as an in-house e-commerce application, and continue to allocate a portion of its annual budget to overseas exhibitions and research and development. The company anticipates a continued reduction in revenue from its healthcare business segment but expects growth in its cosmetic and skincare segment to offset this decline.

Management Comments

• "We are confident in the prospects of our cosmetic and skincare business segment, as these areas show strong potential for growth."
• "We view the post-pandemic era as an exciting chapter, where the resilience of our brand and the loyalty of our customers will play pivotal roles in our continued success."

Industry Context

The beauty market is experiencing significant global growth, projected to reach $580 billion by 2027 (CAGR 6%), with the Asia-Pacific region (excluding China) expected to outpace this at a 7% CAGR. Malaysia's beauty and personal care market is forecasted to grow to $3.58 billion by 2028. The Personal Protective Equipment (PPE) market, including medical facemasks, is also expanding globally to $113 billion by 2029 (CAGR 6%), with APAC holding over 56% market share. Empro Group's strategic pivot aligns with these trends, leveraging increasing consumer purchasing power in ASEAN, tourism recovery in Malaysia, and favorable government policies like the OSHMP 2021-2025 and NIMP 2030 which prioritize health and manufacturing. The rise of a tech-savvy, beauty-conscious youth population (median age 30 in ASEAN) and the expanding wellness industry concept ($5.6 trillion as of 2022) present significant opportunities. While e-commerce growth is strong, the continued relevance of in-store retail (offline channels still 80% of sales) supports Empro's omnichannel strategy.

Comparison to Industry Standards

• For eyebrow pencils, Empro Group competes with luxury Japanese brand Shu Uemura (L'Oréal Group) and Bobbi Brown (The Estée Lauder Companies).
• For its SpaceLift skincare product, Empro Group competes with globally recognized brands such as Clarins, SK-II, Kiehl's (L'Oréal Group), Hada Labo, and Eucerin (Beiersdorf AG).
• Empro Group believes its SpaceLift product is well-positioned against competitors due to its delivered results and broader benefits, including pore minimization, UV protection, and anti-inflammation.
• In the medical face mask segment, Empro Group's primary competitors are Malaysian brands Medicos and Neutrovis.
• The document highlights that many international beauty brands launched after 2005 have not seen exponential growth, with only 4 out of 46 brands (revenues $50M-$200M in 2017) exceeding $400M five years later, suggesting a challenging growth environment that Empro Group aims to navigate strategically.

Management Changes

Corporate Governance

Legal Proceedings

• The company is currently not a party to, and is not aware of any threat of, any legal or administrative proceedings that are likely to have any material and adverse effect on its business, financial condition, cash flow, or results of operations.

Related Party Transactions

• As of December 31, 2024, EMP Solution had a balance of $237,032 due to Mr. Yeoh (CEO and Director) from advances and payments made on behalf of EMP Solution; these amounts are non-interest bearing and due on demand.
• EMP Solution paid Jingga Anggun Sdn Bhd (a company where Mr. Yeoh's son is sole director and Mr. Chin is COO) an aggregate of $1,282,186 in 2024 and $1,526,651 in 2023 for medical facemasks under an exclusive sole distribution agreement. As of December 31, 2024, $468,050 was owed to Jingga Anggun.
• EMP Solution had outstanding trade and other receivables of $10,725 from Mosfac Sdn Bhd (a company where Mr. Yeoh is a 50% shareholder and director) as of December 31, 2024, arising from advances for cosmetic product stock. EMP Solution also had outstanding payables of $7,209 to Mosfac as of the same date from cosmetic stock purchases.
• EMP Solution had outstanding receivables of $0 from Mimo Motor Sdn Bhd (a company where Mr. Yeoh is sole shareholder and director) as of December 31, 2024, down from $29,956 in 2023, arising from payment of expenses.
• EMP Solution had outstanding payables of $23,240 to Brand Multi Plus Sdn Bhd (a company where Mr. Yeoh's son is sole director and shareholder) as of December 31, 2024, arising from the purchase of property, plant and equipment.

Stakeholder Impact

• Shareholders: New investors face immediate and substantial dilution. Future returns are dependent on share price appreciation as no dividends are expected. The founder's majority ownership (controlled company status) may limit the influence of other shareholders.
• Employees: The company maintains a good working relationship with its 33 full-time employees and contract workers, with standard employment agreements including confidentiality and non-compete clauses for senior management.
• Customers: The company's strategic pivot to beauty and skincare, along with investments in new products (SpaceLift, Premio, Mios) and an in-house e-commerce application, aims to enhance customer experience and satisfaction. Product safety and quality are emphasized through rigorous testing and certifications.
• Suppliers: The company relies on a limited number of key ODM/OEM and packaging supply partners (Jingga Anggun, Mosfac), which introduces concentration risk if these relationships are disrupted or if partners fail to meet obligations.
• Creditors: The company's bank borrowings are secured by assets and jointly and severally guaranteed by the Director and his close family member, providing a level of security for creditors.

Next Steps

• Listing Ordinary Shares on the Nasdaq Capital Market under the symbol EMPG.
• Expanding product offerings with new brands like Premio (scheduled for Q2 2025 launch) and Mios (launched Q2 2024), and continued focus on SpaceLift skincare.
• Geographical expansion into new international markets including Europe, India, the United States, Canada, Thailand, Cambodia, UAE, Singapore, Hong Kong, Macau & China, and South Africa within the next five years.
• Investing in new technologies, including the development of an in-house e-commerce application for B2B and B2C customers.
• Allocating a portion of the annual budget to overseas exhibitions and research and development activities to stay updated on industry trends.
• Seeking USFDA approval for medical face masks and SpaceLift for commercial launch in the United States (targeted late Q1 or early Q2 2025).
• Continuing to increase revenue from the healthcare division while further diversifying product offerings within the beauty division.

Key Dates

Recommendation

Keywords

Beauty Products, Healthcare Products, Medical Face Masks, Skincare, Cosmetics, Eyebrow Pencils, IPO, Nasdaq, Malaysia, ASEAN, SpaceLift, EMPG, SEC Filing, F-1/A, Initial Public Offering, Distribution Network, E-commerce, Controlled Company, Risk Factors, Financial Performance, Revenue Diversification, International Expansion